Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Crossveinless-2/CV-2 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB2299SP
This item is not returnable.
View return policy
Description
Crossveinless-2/CV-2/BMPER Monoclonal specifically detects Crossveinless-2/CV-2/BMPER in Mouse samples. It is validated for Western Blot.Specifications
Crossveinless-2/CV-2/BMPER | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
AAH66153 | |
BMPER | |
Mouse myeloma cell line NS0-derived recombinant mouse Crossveinless-2/CV-2 Val34-Arg685 Accession # AAH66153 | |
25 μg | |
Primary | |
Detects mouse Crossveinless-2/CV-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, 100% cross-reactivity with recombinant human CV-2 is observed. | |
Mouse | |
Purified |
Western Blot | |
349920 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
BMP binding endothelial regulator, BMP-binding endothelial regulator precursor protein, BMP-binding endothelial regulator protein, BMPER, Bone morphogenetic protein-binding endothelial cell precursor-derived regulator, CRIM3, crossveinless 2, crossveinless-2, Cv2, CV-2, hCV2, KIAA1965, Protein crossveinless-2 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
168667 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction